Literature DB >> 22315643

An aromatic mystery.

James Reid1, Nick Balcombe, Kris Ghosh.   

Abstract

A case of antiepileptic hypersensitivity syndrome presenting as an acute septic illness is reported. A 67-year-old man, with a history of essential hypertension (treated with amlodipine) and recently diagnosed nocturnal epilepsy (treated with phenytoin), presented initially with an acute pneumonic illness with periorbital oedema. This was treated successfully with antibiotics and his phenytoin was changed to carbamazepine due to concerns regarding the periorbital oedema. He was re-admitted the following month with a history of weight loss, rigors, night sweats and high temperatures. Investigations revealed very high inflammatory markers. Despite extensive tests, no source of infection, autoimmune disease or malignancy was identified. The carbamazepine was then stopped and over the next 5 days the patient's symptoms gradually resolved. The patient's haematological and biochemical abnormalities returned to normal and he was discharged home. Since discharge he has been very well with no further sequelae.

Entities:  

Year:  2010        PMID: 22315643      PMCID: PMC3029051          DOI: 10.1136/bcr.09.2009.2261

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Anticonvulsant hypersensitivity syndrome.

Authors:  C C Vittorio; J J Muglia
Journal:  Arch Intern Med       Date:  1995-11-27

3.  Antiepileptic hypersensitivity syndrome in children.

Authors:  O Bessmertny; R C Hatton; R P Gonzalez-Peralta
Journal:  Ann Pharmacother       Date:  2001-05       Impact factor: 3.154

Review 4.  Antiepileptic drug hypersensitivity syndrome.

Authors:  R G Schlienger; N H Shear
Journal:  Epilepsia       Date:  1998       Impact factor: 5.864

5.  Anticonvulsant hypersensitivity syndrome study of 60 cases.

Authors:  P Bhargava
Journal:  Indian J Dermatol Venereol Leprol       Date:  2001 Nov-Dec       Impact factor: 2.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.